JADENU
As listed in the register: JADENU
360 mg · tablet
- Prescription only
- Everything that fits nowhere else, such as contrast media
- Active substance
- Deferasirox
- Made by
- Novartis Pharmaceuticals Canada Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Exjade). It describes the substance, not this exact product.
Exjade (deferasirox) is an orally active chelator that is selective for iron (as Fe 3+ ).
It is a tridentate ligand that binds iron with high affinity in a 2:1 ratio.
Deferasirox and metabolites are primarily (84% of the dose) excreted in the feces.
The bioavailability (AUC) of deferasirox was variably increased when taken with a meal.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-01-28
Safety of the active substance
From the US prescribing label for the same active substance (Exjade). It describes the substance, not this exact product.
WARNING: RENAL FAILURE, HEPATIC FAILURE, and GASTROINTESTINAL HEMORRHAGE Renal Failure Exjade can cause acute renal failure and death, particularly in patients with comorbidities and those who are in the advanced stages of their hematologic disorders.
- Estimated GFR less than 40 mL/min/1.73 m 2.
- ( 4 ) Patients with poor performance status.
- ( 4 ) Patients with high-risk myelodysplastic syndrome (MDS).
- ( 4 ) Patients with advanced malignancies.
The most frequently occurring (greater than 5%) adverse reactions are diarrhea, rash, and nausea.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States14 matching products
European UnionNo exact match for this strength and form
Spain16 matching products
- DEFERASIROX ABDI 360 mg · comprimido recubierto con película
- DEFERASIROX ACCORD 360 mg · comprimido recubierto con película
- DEFERASIROX ALEMBIC 360 mg · comprimido recubierto con película
- DEFERASIROX AUROVITAS 360 mg · comprimido recubierto con película
- DEFERASIROX PHARMATHEN 360 mg · comprimido recubierto con película
- DEFERASIROX RATIOPHARM 360 mg · comprimido recubierto con película
- DEFERASIROX STADA 360 mg · comprimido recubierto con película
- DEFERASIROX SUN 360 mg · comprimido recubierto con película
Netherlands22 matching products
- Deferasirox Teva 360 mg 360 mg · filmomhulde tablet2 makers
- Deferasirox Abdi 360 mg filmomhulde tabletten 360 mg · filmomhulde tablet
- Deferasirox Accord 360 mg 360 mg · filmomhulde tablet
- Deferasirox Amarox 360 mg filmomhulde tabletten 360 mg · filmomhulde tablet
- Deferasirox Aurobindo 360 mg 360 mg · filmomhulde tablet
- Deferasirox betapharm 360 mg 360 mg · filmomhulde tablet
- Deferasirox DOC 360 mg 360 mg · filmomhulde tablet
- Deferasirox MSN 360 mg filmomhulde tabletten 360 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Novartis Pharmaceuticals Canada Inc |
|---|---|
| Active substance | Deferasirox |
| Used in | Everything that fits nowhere else, such as contrast media |
| Strength | 360 mg |
| Form | tablet |
| Classification | V03AC03 · Everything that fits nowhere else, such as contrast media |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02452235 |
| DPD drug code | 93866 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.